Patients with mucinous adenocarcinoma had larger primary lesions, higher preoperative CEA levels, a deeper depth of invasion, higher rates of nodal and distant metastasis, and more metastatic sites. This evidence concerns the gene CEACAM5 and mucinous adenocarcinoma.